Severin Schwan

Severin Schwan graduated from the Akademisches Gymnasium Innsbruck and then studied economics at the University of Innsbruck, University of York and University of Oxford as well as law at the University of Innsbruck.[3] He completed both subjects in 1991 with a master's degree and acquired the title Mag. iur. and Mag. rer. soc. oec. After obtaining his Doctorate in Law in 1993, he has held various positions within the Roche Group.[4]

Schwan started his career as a trainee at the Roche office in Basel. He has worked in a number of positions across the globe for Roche. He was appointed CEO of the Roche Group at its Annual General Meeting on March 4, 2008, replacing Franz B. Humor.[5] Previously, Schwan was managing director of Roche's Diagnostics Division.

He has been a member of the Board of Directors of Roche Holding AG since 2013. At the Annual General Meeting on March 14, 2023, he was elected chairman of the Board of Directors, succeeding Christoph Franz.[6] Thomas Schinecker became Schwan's successor as CEO.[7]

From 2014 to 2022, he was a member of the board of directors of Credit Suisse, and from 2017 its vice chairman. He stepped down from the position of vice-chair in March 2022.[8][9]

He served on the board at Chugai Pharmaceutical Co., Ltd. Schwan has been a member of the International Business Leaders Advisory Council for the Mayor of Shanghai (IBLAC) since 2009 and Vice President since 2022.[10]

From 2016 to 2020, he was Vice President of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).[11]

Schwan is of Austrian nationality. Schwan is married, has three children and lives in the Basel suburb of Riehen.[12][13] He is a citizen of Austria, Germany and Switzerland.[14][15]